Dr. Maria Farooq completed a Bachelor of Medicine and Surgery from Punjab Medical College in Pakistan. She was awarded three Gold Medals for first position in Surgery, Distinction in Gynecology, and first position in the MBBS exam. Prior to coming to the U.S., Dr. Farooq worked in the Department of Pathology, where she managed several tasks as a House Officer in Clinical Pathology at Allied Hospital and then, she served as an intern in the department of Surgery at the District Head Quarter Hospital in Faisalabad. During this time Dr. Farooq also participated in research at John’s Hopkins University in Baltimore, and with the department of Endocrinology at University at Buffalo, in Buffalo NY.
Dr. Farooq pursued and completed her Internal Medicine Residency at the University at Buffalo getting her board certification in Internal Medicine during the process. Directly after her residency Dr. Farooq pursued her passion for the field of Rheumatology and was accepted for a Rheumatology Fellowship position at the University of Cincinnati, where she earned her board certification. After completion of her fellowship in Rheumatology at the University of Cincinnati, she worked as a Rheumatologist at Lexington Medical Center in South Carolina.
Dr. Farooq joined the College of Medicine in 2019 as a clinician at the UCF Gateway location in the area of Rheumatology. She has about 3 years of experience working as a Rheumatologist. Dr. Farooq has participated in a number of presentations, including various Grand Rounds sessions at the University of Cincinnati, as well as research surrounding the meta-analysis of effects of Raloxifene on cardiovascular system and breast and uterine malignancies and the role of Chloroquine in advance malignancies. She is certified in Musculoskeletal US and is trained in performing rheumatologic procedures and diagnostic tests with the use of ultrasound techniques for minimal discomfort to the patient. Dr. Farooq’s work was recently honored with the Osler Award, in recognition of outstanding instruction in Rheumatology and for modeling compassion towards patients, and a dedication to excellence.
- Effect of raloxifene therapy on venous thromboembolism in postmenopausal women. A Meta-analysis. Thromb Haemost, Feb ’99 2008 (2):338-42 PMID: 18278183; Adomaityte J, Farooq M, Qayyum R.
- Phase 1 study of use of chloroquine and hydroxychloroquine in conjunction with Carboplatin and gemcitabine in advance solid tumors.